FDA’s Revised Electronic Source Data Guidance Less Specific On How Data Should Flow
This article was originally published in The Pink Sheet Daily
FDA issues its second draft on the topic in two years, going back to the drawing board after comments from industry, but BIO still hasn’t persuaded the agency to explicitly exempt electronic diaries.
You may also be interested in...
Minnesota device makers petition FDA. Invacare lays off workers following FDA consent decree. More regulatory news.
News on FDA workforce troubles, feedback on CDRH’s eCopy policy and more.
FDA’s food, dietary supplement and cosmetics division seeks funding to support its artificial intelligence capabilities, including post-market surveillance and speedy interventions in instances where safety issues arise. Also of note, the agency cites UV filters’ effects on the skin microbiome as a research priority in its fiscal 2021 budget justification to Congress.